Karpus Investment Management’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.45M Sell
141,442
-216
-0.2% -$8.91K 0.17% 124
2025
Q4
$5.83M Buy
141,658
+73,339
+107% +$2.9M 0.18% 120
2025
Q3
$2.54M Buy
68,319
+15,647
+30% +$569K 0.08% 147
2025
Q2
$1.92M Buy
52,672
+957
+2% +$34.7K 0.06% 158
2025
Q1
$2M Sell
51,715
-14,243
-22% -$565K 0.06% 154
2024
Q4
$2.5M Buy
65,958
+45,586
+224% +$1.82M 0.07% 152
2024
Q3
$854K Buy
20,372
+2,509
+14% +$104K 0.02% 190
2024
Q2
$730K Hold
17,863
0.02% 199
2024
Q1
$740K Sell
17,863
-140
-0.8% -$5.86K 0.02% 205
2023
Q4
$728K Buy
+18,003
New +$688K 0.02% 210
2018
Q2
Sell
-20,806
Closed -$728K 178
2018
Q1
$728K Buy
+20,806
New +$740K 0.03% 121

Other funds holding BME

Karpus Investment Management's BME Position: Q1 2026 in Review

Karpus Investment Management reduced its BlackRock Health Sciences Trust (BME) stake by 0.15% in Q1 2026, selling an estimated $8.91K and leaving 141,442 shares worth $5.45M. The position accounts for 0.17% of the portfolio, ranked #124.

Karpus Investment Management first reported a position in BME in Q1 2018 and has held it in 11 quarters since. The position peaked at $5.83M in Q4 2025. 76 funds tracked by Wall St. Rank hold BME as of Q1 2026.

  • Karpus Investment Management held 141,442 shares of BlackRock Health Sciences Trust worth $5.45M as of Q1 2026.
  • Karpus Investment Management sold 216 BlackRock Health Sciences Trust shares in Q1 2026, an estimated $8.91K.
  • BlackRock Health Sciences Trust made up 0.17% of Karpus Investment Management's portfolio in Q1 2026, its #124 holding.
  • Karpus Investment Management first reported a position in BlackRock Health Sciences Trust in Q1 2018 and has held it in 11 quarters since.
  • Karpus Investment Management's BlackRock Health Sciences Trust position peaked at $5.83M in Q4 2025.
  • 76 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q1 2026.

Based on Karpus Investment Management's 13F filing for Q1 2026, filed 14 May 2026.